These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 24327607

  • 1. Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program.
    Hindi SM, Mishra V, Bhatnagar S, Tajrishi MM, Ogura Y, Yan Z, Burkly LC, Zheng TS, Kumar A.
    FASEB J; 2014 Mar; 28(3):1398-411. PubMed ID: 24327607
    [Abstract] [Full Text] [Related]

  • 2. The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.
    Mittal A, Bhatnagar S, Kumar A, Lach-Trifilieff E, Wauters S, Li H, Makonchuk DY, Glass DJ, Kumar A.
    J Cell Biol; 2010 Mar 22; 188(6):833-49. PubMed ID: 20308426
    [Abstract] [Full Text] [Related]

  • 3. The TWEAK-Fn14 dyad is involved in age-associated pathological changes in skeletal muscle.
    Tajrishi MM, Sato S, Shin J, Zheng TS, Burkly LC, Kumar A.
    Biochem Biophys Res Commun; 2014 Apr 18; 446(4):1219-1224. PubMed ID: 24680686
    [Abstract] [Full Text] [Related]

  • 4. The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting.
    Bhatnagar S, Kumar A.
    Curr Mol Med; 2012 Jan 18; 12(1):3-13. PubMed ID: 22082477
    [Abstract] [Full Text] [Related]

  • 5. TWEAK and TRAF6 regulate skeletal muscle atrophy.
    Kumar A, Bhatnagar S, Paul PK.
    Curr Opin Clin Nutr Metab Care; 2012 May 18; 15(3):233-9. PubMed ID: 22366923
    [Abstract] [Full Text] [Related]

  • 6. Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice.
    Meijboom KE, Sutton ER, McCallion E, McFall E, Anthony D, Edwards B, Kubinski S, Tapken I, Bünermann I, Hazell G, Ahlskog N, Claus P, Davies KE, Kothary R, Wood MJA, Bowerman M.
    Skelet Muscle; 2022 Jul 28; 12(1):18. PubMed ID: 35902978
    [Abstract] [Full Text] [Related]

  • 7. Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction.
    Sato S, Ogura Y, Tajrishi MM, Kumar A.
    FASEB J; 2015 Mar 28; 29(3):988-1002. PubMed ID: 25466899
    [Abstract] [Full Text] [Related]

  • 8. DNA methyltransferase 3a and mitogen-activated protein kinase signaling regulate the expression of fibroblast growth factor-inducible 14 (Fn14) during denervation-induced skeletal muscle atrophy.
    Tajrishi MM, Shin J, Hetman M, Kumar A.
    J Biol Chem; 2014 Jul 18; 289(29):19985-99. PubMed ID: 24895120
    [Abstract] [Full Text] [Related]

  • 9. The role of alterations in mitochondrial dynamics and PGC-1α over-expression in fast muscle atrophy following hindlimb unloading.
    Cannavino J, Brocca L, Sandri M, Grassi B, Bottinelli R, Pellegrino MA.
    J Physiol; 2015 Apr 15; 593(8):1981-95. PubMed ID: 25565653
    [Abstract] [Full Text] [Related]

  • 10. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine.
    Dogra C, Changotra H, Wedhas N, Qin X, Wergedal JE, Kumar A.
    FASEB J; 2007 Jun 15; 21(8):1857-69. PubMed ID: 17314137
    [Abstract] [Full Text] [Related]

  • 11. Controversies in TWEAK-Fn14 signaling in skeletal muscle atrophy and regeneration.
    Pascoe AL, Johnston AJ, Murphy RM.
    Cell Mol Life Sci; 2020 Sep 15; 77(17):3369-3381. PubMed ID: 32200423
    [Abstract] [Full Text] [Related]

  • 12. Targeted ablation of Fn14 receptor improves exercise capacity and inhibits neurogenic muscle atrophy.
    Tomaz da Silva M, Joshi AS, Koike TE, Roy A, Mathukumalli K, Sopariwala DH, Narkar VA, Kumar A.
    FASEB J; 2022 Dec 15; 36(12):e22666. PubMed ID: 36412933
    [Abstract] [Full Text] [Related]

  • 13. TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases.
    Bhatnagar S, Mittal A, Gupta SK, Kumar A.
    J Cell Physiol; 2012 Mar 15; 227(3):1042-51. PubMed ID: 21567392
    [Abstract] [Full Text] [Related]

  • 14. TWEAK promotes exercise intolerance by decreasing skeletal muscle oxidative phosphorylation capacity.
    Sato S, Ogura Y, Mishra V, Shin J, Bhatnagar S, Hill BG, Kumar A.
    Skelet Muscle; 2013 Jul 08; 3(1):18. PubMed ID: 23835416
    [Abstract] [Full Text] [Related]

  • 15. TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction.
    Sato S, Ogura Y, Kumar A.
    Front Immunol; 2014 Jul 08; 5():18. PubMed ID: 24478779
    [Abstract] [Full Text] [Related]

  • 16. Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1.
    He Z, Song Q, Yu Y, Liu F, Zhao J, Un W, Da X, Xu C, Yao Y, Wang QK.
    J Cachexia Sarcopenia Muscle; 2023 Apr 08; 14(2):978-991. PubMed ID: 36696895
    [Abstract] [Full Text] [Related]

  • 17. Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice.
    Mittal A, Bhatnagar S, Kumar A, Paul PK, Kuang S, Kumar A.
    Am J Pathol; 2010 Oct 08; 177(4):1732-42. PubMed ID: 20724600
    [Abstract] [Full Text] [Related]

  • 18. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription.
    Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, Goldberg AL, Spiegelman BM.
    Proc Natl Acad Sci U S A; 2006 Oct 31; 103(44):16260-5. PubMed ID: 17053067
    [Abstract] [Full Text] [Related]

  • 19. Heightened TWEAK-NF-κB signaling and inflammation-associated fibrosis in paralyzed muscles of men with chronic spinal cord injury.
    Yarar-Fisher C, Bickel CS, Kelly NA, Stec MJ, Windham ST, McLain AB, Oster RA, Bamman MM.
    Am J Physiol Endocrinol Metab; 2016 May 01; 310(9):E754-61. PubMed ID: 26931128
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.